PYPeipei Yang

Peipei Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peipei Yang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • US Risk Stratification System for Follicular Thyroid Neoplasms

    by Jianming Li, Chao Li, XiaoHui Zhou, JiuPing Huang, Peipei Yang, Yuancheng Cang, Hongyan Zhai, RenXiang Huang, Yang Mu, Xiangnan Gou, et al.

    Background Preoperative assessment of follicular thyroid neoplasms is challenging using the current US risk stratification systems (RSSs) that are applicable to papillary thyroid neoplasms. Purpose To develop a US feature-based RSS for differentiating between follicular thyroid adenoma (FTA) and follicular thyroid carcinoma (FTC) in biopsy-proven follicular neoplasm and compare it with existing RSSs. Materials and Methods This retrospective multicenter study included consecutive adult patients who underwent conventional US and received a final diagnosis of follicular thyroid neoplasm from seven centers between January 2018 and December 2022. US images from a pretraining data set were used to improve readers' understanding of the US characteristics of the FTC and FTA. Univariable and multivariable logistic regression analyses were used to assess the association of qualitative US features with FTC in a training data set. Features with P < .05 were used to construct a prediction model (follicular tumor model, referred to as F model) and RSS for follicular neoplasms using the Thyroid Imaging Reporting and Data System (TI-RADS). Area under the receiver operating characteristic curve (AUC) was compared between follicular TI-RADS (hereafter, F-TI-RADS) and existing RSS (American College of Radiology [ACR] TI-RADS, Korean Society of Thyroid Radiology and Korean Society of Radiology TI-RADS [hereafter, referred to as K-TI-RADS], and Chinese TI-RADS [hereafter, referred to as C-TI-RADS]) in a validation data set. Results The pretraining, training, and validation data sets included 30 (mean age, 47.6 years ± 16.0 [SD]; 16 male patients; FTCs, 30 of 60 [50.0%]), 703 (mean age, 47.9 years ± 14.5; 530 female patients; FTCs, 188 of 703 [26.7%]), and 155 (mean age, 49.9 years ± 13.3 [SD]; 155 female patients; FTCs, 43 of 155 [27.7%]) patients. In the validation data set, the F-TI-RADS showed improved performance for differentiating between FTA and FTC (AUC, 0.81; 95% CI: 0.71, 0.86) compared with ACR TI-RADS (AUC, 0.74; 95% CI: 0.66, 0.80; P = .02), K-TI-RADS (AUC, 0.69; 95% CI: 0.61, 0.76; P = .002), and C-TI-RADS (AUC, 0.68; 95% CI: 0.60, 0.75; P = .002). Conclusion F-TI-RADS outperformed existing RSSs for differentiating between FTC and FTA. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Baumgarten in this issue.


  • Open Access

    Photodynamic eradication of intratumoral microbiota with bacteria‐targeted micelles overcomes gemcitabine resistance of pancreatic cancer

    by Renfa Liu, Huanyu Yang, Shuai Qu, Peipei Yang, Xin Zhi, Yunxue Xu, Zhifei Dai, Linxue Qian

    Increasing evidence suggests that intratumoral microbiota plays a pivotal role in tumor progression, immunosurveillance, metastasis, and chemosensitivity. Particularly, in pancreatic ductal adenocarcinoma, tumor‐resident Gammaproteobacteria could transform the chemotherapeutic drug gemcitabine (Gem) into its inactive form, thus rendering chemotherapy ineffective. Herein, a strategy for selectively eradicating intratumoral bacteria was described for overcoming Gem resistance in a pancreatic cancer animal model. An antimicrobial peptide was linked with photosensitizer through a poly (ethylene glycol) chain, which can self‐assemble into micelles with a diameter of ∼20 nm. The micelles could efficiently kill bacteria under light irradiation by inducing membrane depolarization, thereby inhibiting Gem metabolism. In a bacteria‐resident pancreatic cancer animal model, the selective photodynamic eradication of intratumoral bacteria was demonstrated to efficiently reverse Gem resistance. This research highlights antibacterial photodynamic therapy as a promising adjuvant strategy for cancer therapy by modulating intratumoral microbiota.


  • Open Access

    Building a Predictive Model and Survival Analysis for Distant Metastases in Differentiated Thyroid Carcinoma: A Three Center Retrospective Study

    by Huang Jiuping, Li Huarong, Peipei Yang, Wang Zhendong, Feng Pei, Linxue Qian

    BACKGROUNDː Distant metastases (DM) occur rarely and are associated with poor outcomes in patients with differentiated thyroid carcinoma (DTC). The aim of this study was to explore potential risk factors of DM in DTC and build a decision-tree model. METHODSː The medical records of 15,591 patients who were diagnosed with DTC after initial surgery in three medical centers (2000 to 2018) were reviewed and 37 patients (test group) and 14 patients (validation group) with DM and detailed clinicopathologic characteristics were identified. Patients with no evidence of disease (NED) postoperatively were randomly sampled to create a control group in a 4:1 ratio. RESULTSː Multiple factors, including median age, extrathyroidal extension (ETE), AJCC stage, position, histological type, and diameter differed significantly between the DM and NED groups (P˂0.001) in univariate and multivariate analysis. AJCC stage and diameter of the primary tumor made the greatest contributions to prognosis according to decision-tree analysis and a random forest algorithm. The predictive model constructed from these data achieved 100% accuracy of classification. External validation confirmed that this model has 100% accuracy of classification. In addition, histology and ETE were found to be independent predictors of survival in patients with metachronous metastases. CONCLUSIONSː This study optimized the weight of risk factors, including AJCC stage and diameter of primary tumor, in predicting DM in patients with DTC. Our predictive model provides a strong tool for prediction that may potentially affect clinical decision-making.


  • Open Access

    Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma

    by Peipei Yang, Jianming Li, Haoyu Jing, Qiyang Chen, Xinxin Song, Linxue Qian

    There is a consensus that central compartment lymph node dissection or modified radical lateral neck dissection should be performed in papillary thyroid microcarcinoma (PTMC) patients with lymph node metastases. Prophylactic central lymph node dissection (PCLND) in patients with clinically node-negative (cN0) PTMC to reduce locoregional recurrence (LRR) rate and improve prognosis remains controversial. The present study aimed to analyze the effect of PCLND on LRR and postoperative complications of PTMC in cN0 patients. We reviewed a cohort of patients with cN0 PTMC who underwent surgery between January 1997 and October 2019. The patients were divided into the PCLND and no lymph node dissection (NLND) groups. Kaplan–Meier curves were constructed to estimate 15-year locoregional recurrence-free survival rate of the two groups, and the difference was compared by the log-rank test. Three Cox regression models were performed to evaluate the correlation between PCLND and LRR. All patients underwent thyroidectomy, and 25 patients developed LRR; of whom, 23 underwent PCLND at initial surgery and 2 went without lymph node dissection. Cox regression analysis showed that PCLND had no effect on LRR. Postoperative hematoma and permanent recurrent laryngeal nerve injury did not occur in the NLND group, and their incidences were 0.5% and 0.3% in the PCLND group, respectively. PCLND had no significant correlation with LRR in patients with cN0 PTMC, and the absolute benefit for PTMC was small.


  • Open Access

    A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma

    by Yuan Zu, Yujiang Liu, Junfeng Zhao, Peipei Yang, Jianming Li, Linxue Qian

    The optimal treatment method for papillary thyroid microcarcinoma (PTMC) is lacking consensus. Here we aimed to compare the efficacy and safety of surgery and microwave ablation (MWA) for PTMC.The ...